chr11-1244706-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002458.3(MUC5B):​c.7826T>C​(p.Leu2609Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0236 in 1,602,980 control chromosomes in the GnomAD database, including 690 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L2609L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.023 ( 46 hom., cov: 31)
Exomes 𝑓: 0.024 ( 644 hom. )

Consequence

MUC5B
NM_002458.3 missense

Scores

16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -3.28

Publications

7 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B-AS1 (HGNC:53936): (MUC5B antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0044881403).
BP6
Variant 11-1244706-T-C is Benign according to our data. Variant chr11-1244706-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 403181.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0231 (3447/149404) while in subpopulation NFE AF = 0.0283 (1910/67434). AF 95% confidence interval is 0.0273. There are 46 homozygotes in GnomAd4. There are 1696 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 46 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUC5BNM_002458.3 linkc.7826T>C p.Leu2609Pro missense_variant Exon 31 of 49 ENST00000529681.5 NP_002449.2
MUC5B-AS1NR_157183.1 linkn.57-2068A>G intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUC5BENST00000529681.5 linkc.7826T>C p.Leu2609Pro missense_variant Exon 31 of 49 5 NM_002458.3 ENSP00000436812.1
MUC5B-AS1ENST00000532061.2 linkn.57-2068A>G intron_variant Intron 1 of 1 5

Frequencies

GnomAD3 genomes
AF:
0.0231
AC:
3446
AN:
149274
Hom.:
46
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0160
Gnomad AMI
AF:
0.00330
Gnomad AMR
AF:
0.0232
Gnomad ASJ
AF:
0.0120
Gnomad EAS
AF:
0.00501
Gnomad SAS
AF:
0.0116
Gnomad FIN
AF:
0.0346
Gnomad MID
AF:
0.0483
Gnomad NFE
AF:
0.0283
Gnomad OTH
AF:
0.0233
GnomAD2 exomes
AF:
0.0134
AC:
3275
AN:
245272
AF XY:
0.0131
show subpopulations
Gnomad AFR exome
AF:
0.0103
Gnomad AMR exome
AF:
0.0102
Gnomad ASJ exome
AF:
0.00937
Gnomad EAS exome
AF:
0.00375
Gnomad FIN exome
AF:
0.0228
Gnomad NFE exome
AF:
0.0169
Gnomad OTH exome
AF:
0.0152
GnomAD4 exome
AF:
0.0236
AC:
34309
AN:
1453576
Hom.:
644
Cov.:
147
AF XY:
0.0232
AC XY:
16768
AN XY:
723102
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0139
AC:
465
AN:
33336
American (AMR)
AF:
0.0136
AC:
606
AN:
44482
Ashkenazi Jewish (ASJ)
AF:
0.0150
AC:
390
AN:
26052
East Asian (EAS)
AF:
0.00517
AC:
205
AN:
39614
South Asian (SAS)
AF:
0.00893
AC:
768
AN:
86050
European-Finnish (FIN)
AF:
0.0288
AC:
1529
AN:
53154
Middle Eastern (MID)
AF:
0.0268
AC:
152
AN:
5674
European-Non Finnish (NFE)
AF:
0.0260
AC:
28763
AN:
1105150
Other (OTH)
AF:
0.0238
AC:
1431
AN:
60064
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.332
Heterozygous variant carriers
0
2149
4298
6446
8595
10744
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1024
2048
3072
4096
5120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0231
AC:
3447
AN:
149404
Hom.:
46
Cov.:
31
AF XY:
0.0232
AC XY:
1696
AN XY:
72992
show subpopulations
African (AFR)
AF:
0.0160
AC:
642
AN:
40170
American (AMR)
AF:
0.0232
AC:
349
AN:
15048
Ashkenazi Jewish (ASJ)
AF:
0.0120
AC:
41
AN:
3428
East Asian (EAS)
AF:
0.00502
AC:
25
AN:
4982
South Asian (SAS)
AF:
0.0116
AC:
54
AN:
4656
European-Finnish (FIN)
AF:
0.0346
AC:
361
AN:
10424
Middle Eastern (MID)
AF:
0.0515
AC:
14
AN:
272
European-Non Finnish (NFE)
AF:
0.0283
AC:
1910
AN:
67434
Other (OTH)
AF:
0.0231
AC:
48
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
149
298
448
597
746
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0207
Hom.:
21
Bravo
AF:
0.0218
ESP6500AA
AF:
0.00407
AC:
17
ESP6500EA
AF:
0.0104
AC:
87
ExAC
AF:
0.0204
AC:
2470

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.74
CADD
Benign
0.49
DANN
Benign
0.47
DEOGEN2
Benign
0.015
T
Eigen
Benign
-1.7
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.0012
N
LIST_S2
Benign
0.17
T
MetaRNN
Benign
0.0045
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.69
N
PhyloP100
-3.3
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-0.69
N
REVEL
Benign
0.0050
Sift
Benign
0.099
T
Vest4
0.034
ClinPred
0.00048
T
GERP RS
-1.6
Varity_R
0.070
gMVP
0.15
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2943496; hg19: chr11-1265936; COSMIC: COSV71596163; API